These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3566916)
1. Interaction of Eglin c with polymorphonuclear cells: evidence for binding to the cell surface. Braun NJ; Schnebli HP Biol Chem Hoppe Seyler; 1987 Feb; 368(2):155-61. PubMed ID: 3566916 [TBL] [Abstract][Full Text] [Related]
2. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation. Renesto P; Ferrer-Lopez P; Chignard M Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin. Okada Y; Tsuboi S; Tsuda Y; Nakabayashi K; Nagamatsu Y; Yamamoto J Biochem Biophys Res Commun; 1989 May; 161(1):272-5. PubMed ID: 2730658 [TBL] [Abstract][Full Text] [Related]
4. Eglin C and heparin inhibition of platelet activation induced by cathepsin G or human neutrophils. Renesto P; Ferrer-Lopez P; Chignard M Ann N Y Acad Sci; 1991; 624():321-4. PubMed ID: 2064235 [No Abstract] [Full Text] [Related]
5. Amino acids and peptides. XXVIII. Synthesis of peptide fragments related to eglin c and studies on the relationship between their structure and effects on human leukocyte elastase, cathepsin G and alpha-chymotrypsin. Tsuboi S; Nakabayashi K; Matsumoto Y; Teno N; Tsuda Y; Okada Y; Nagamatsu Y; Yamamoto J Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2369-76. PubMed ID: 2285973 [TBL] [Abstract][Full Text] [Related]
6. Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G. Braun NJ; Bodmer JL; Virca GD; Metz-Virca G; Maschler R; Bieth JG; Schnebli HP Biol Chem Hoppe Seyler; 1987 Apr; 368(4):299-308. PubMed ID: 3649242 [TBL] [Abstract][Full Text] [Related]
7. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to human leukocyte elastase, bovine alpha-chymotrypsin and subtilisin Carlsberg: thermodynamic study. Ascenzi P; Amiconi G; Menegatti E; Guarneri M; Bolognesi M; Schnebli HP J Enzyme Inhib; 1988; 2(3):167-72. PubMed ID: 3071573 [TBL] [Abstract][Full Text] [Related]
8. Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes. Steinmeyer J; Kalbhen DA Arzneimittelforschung; 1991 Jan; 41(1):77-80. PubMed ID: 1710897 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils. Renesto P; Chignard M J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399 [TBL] [Abstract][Full Text] [Related]
10. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453 [TBL] [Abstract][Full Text] [Related]
11. Eglin c, a pharmacologically active elastase inhibitor. Schnebli HP; Seemüller U; Fritz H; Maschler R; Liersch M; Virca GD; Bodmer JL; Snider GL; Lucey EC; Stone PG Eur J Respir Dis Suppl; 1985; 139():66-70. PubMed ID: 3862612 [TBL] [Abstract][Full Text] [Related]
12. Protease inhibitor eglin-c affects superoxide anion release but not bacterial killing by human polymorphonuclear leukocytes. Esposito AL; Clark CA; Poirier WJ; Kephart PA Exp Lung Res; 1988; 14(6):743-56. PubMed ID: 2850161 [TBL] [Abstract][Full Text] [Related]
13. The effect of Eglin C on the function of human neutrophils in vitro. Suter S; Chevallier I Biol Chem Hoppe Seyler; 1988 Jul; 369(7):573-8. PubMed ID: 2852014 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin. Okada Y; Tsuboi S; Tsuda Y; Nagamatsu Y; Yamamoto J FEBS Lett; 1990 Oct; 272(1-2):113-6. PubMed ID: 2226822 [TBL] [Abstract][Full Text] [Related]
15. Heparin protects cathepsin G against inhibition by protein proteinase inhibitors. Ermolieff J; Boudier C; Laine A; Meyer B; Bieth JG J Biol Chem; 1994 Nov; 269(47):29502-8. PubMed ID: 7961933 [TBL] [Abstract][Full Text] [Related]
17. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620 [TBL] [Abstract][Full Text] [Related]
18. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. Lomas DA; Stone SR; Llewellyn-Jones C; Keogan MT; Wang ZM; Rubin H; Carrell RW; Stockley RA J Biol Chem; 1995 Oct; 270(40):23437-43. PubMed ID: 7559504 [TBL] [Abstract][Full Text] [Related]
19. Amino acids and peptides. XXIX. Synthesis of peptide fragments related to active center of eglin c and studies on the relationship between their structure and their inhibitory activity against cathepsin G and alpha-chymotrypsin. Nakabayashi K; Tsuboi S; Fujimoto T; Okada Y; Nagamatsu Y; Yamamoto J Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3249-52. PubMed ID: 2092930 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by elastase inhibitors of the formyl Met Leu Phe-induced chemotaxis of rat polymorphonuclear leukocytes. Hornebeck W; Soleilhac JM; Tixier JM; Moczar E; Robert L Cell Biochem Funct; 1987 Apr; 5(2):113-22. PubMed ID: 3495371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]